Accueil >
Publications >
Real-life efficacy of osimertinib in pretreated patients with advanced non-small cell lung cancer harboring EGFR T790M mutation

Real-life efficacy of osimertinib in pretreated patients with advanced non-small cell lung cancer harboring EGFR T790M mutation

1 janv. 2019Lung Cancer

DOI : 10.1016/j.lungcan.2018.11.037

Auteurs

Jean Bernard Auliac, Maurice Pérol, David Planchard, Isabelle Monnet, Marie Wislez, Hélène Doubre, Florian Guisier, Eric Pichon, Laurent Greillier, Bénédicte Mastroianni, Chantal Decroisette, Roland Schott, Sylvestre Le Moulec, Jennifer Arrondeau, Alexis B. Cortot, Laurence Gerinière, Aldo Renault, Catherine Daniel, Lionel Falchero, Christos Chouaid